• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Menopause Treatment Companies

    ID: MRFR/Pharma/3160-CR
    200 Pages
    Rahul Gotadki
    April 2025

    Menopause treatment companies specialize in developing and providing products, therapies, and services to help women manage the symptoms and health-related challenges associated with menopause, a natural phase of the female reproductive cycle. Menopause typically occurs between the ages of 45 and 55 and can lead to various physical and psychological changes.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Menopause Treatment Market

    Menopause Treatment Key Companies*Disclaimer: List of key companies in no particular orderLatest Menopause treatment Companies Update



    • August 2023: As the most popular home pregnancy and fertility test brand, Clearblue is now offering tests for the menopause as well. More than two-thirds of women entering or experiencing menopause report feeling unprepared for the transition, and only 45% report having sufficient information to handle the transition. In response, Clearblue has introduced the Clearblue Menopause Stage Indicator, the first and only device of its kind that uses a woman's urine FSH values, age, and menstrual history to predict when she is likely to enter menopause.




    • March 2023: Aptorum Group Limited, a clinical-stage biopharmaceutical company focused on developing novel therapeutics to tackle unmet medical needs, made an exciting announcement in March 2023: the commercial launch of NativusWell, a new dietary supplement supporting women's health throughout the Menopausal cycles, aimed at the China market. NativusWell is now available for distribution in China thanks to the company's partnership with JD.com, one of the country's major online marketplaces.




    • January 2023: Lenzetto, a unique transdermal estradiol spray, has been released by Themis Medicare to treat menopausal symptoms in the Indian market. Lenzetto is a menopause medication that has been licensed by the US Food and Drug Administration and the European Medicines Agency. In Europe, Gedeon Richter produces Lenzetto. Themis Medicare states that Gedeon Richter, Hungary is where Lenzetto is made and imported from. Transdermal sprays like Lenzetto's are convenient since they allow for "metered dose application" across a limited region of skin. Lenzetto appears to provide gynecologists with an effective and convenient treatment alternative for addressing menopausal symptoms in women.


    List of Menopause treatment Key companies in the market

    • Novo Nordisk A/S (Denmark)

    • Pfizer Inc. (US)

    • Allergan (Ireland)

    • Eli Lily and Company (US)

    • Emcure Pharmaceuticals Ltd (India)

    • Novartis AG (Switzerland)

    • Cipla Inc. (India)

    • Teva Pharmaceuticals (Israel)

    • Merck & Co. Inc. (US)

    • Abbott Laboratories (US)